These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

819 related items for PubMed ID: 25952733

  • 1. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
    Goense L, van Rossum PS, Reitsma JB, Lam MG, Meijer GJ, van Vulpen M, Ruurda JP, van Hillegersberg R.
    J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733
    [Abstract] [Full Text] [Related]

  • 2. Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
    Goense L, Meziani J, van Rossum PSN, Wessels FJ, Meijer GJ, Lam MGEH, van Hillegersberg R, Ruurda JP.
    Nucl Med Commun; 2018 Jul; 39(7):645-651. PubMed ID: 29672463
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Kroese TE, Goense L, van Hillegersberg R, de Keizer B, Mook S, Ruurda JP, van Rossum PSN.
    Dis Esophagus; 2018 Dec 01; 31(12):. PubMed ID: 29917073
    [Abstract] [Full Text] [Related]

  • 5. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 6. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
    Wu LM, Hu JN, Hua J, Gu HY, Zhu J, Xu JR.
    J Gastroenterol Hepatol; 2012 Mar 01; 27(3):472-80. PubMed ID: 21916986
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y, Wang L, Jiang X, She W, He L, Hu G.
    Nucl Med Commun; 2016 Nov 01; 37(11):1180-8. PubMed ID: 27428888
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.
    Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Kulkarni M, Laskar SG, Rangarajan V.
    Nucl Med Commun; 2014 Aug 01; 35(8):864-9. PubMed ID: 24751701
    [Abstract] [Full Text] [Related]

  • 12. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.
    Cochrane Database Syst Rev; 2015 Sep 29; 2015(9):CD009263. PubMed ID: 26417712
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T, Meng N, Chi D, Zhao Y, Wang K, Luo Y.
    Cell Biochem Biophys; 2015 Jun 29; 72(2):443-51. PubMed ID: 25737131
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J, Pei S, Zhu X.
    Oral Oncol; 2016 Jan 29; 52():11-7. PubMed ID: 26547126
    [Abstract] [Full Text] [Related]

  • 15. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F, Incerti E, Colicchia M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Moschini M, Gallina A, Karnes JR, Lowe V, Fanti S, Schiavina R, Rambaldi I, Ficarra V, Evangelista L.
    Abdom Radiol (NY); 2018 Sep 29; 43(9):2391-2399. PubMed ID: 29302738
    [Abstract] [Full Text] [Related]

  • 16. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.
    Nucl Med Commun; 2012 Jun 29; 33(6):591-6. PubMed ID: 22334135
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
    Sheikhbahaei S, Taghipour M, Ahmad R, Fakhry C, Kiess AP, Chung CH, Subramaniam RM.
    AJR Am J Roentgenol; 2015 Sep 29; 205(3):629-39. PubMed ID: 26295652
    [Abstract] [Full Text] [Related]

  • 18. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
    Liu F, Zhang Q, Zhu D, Liu F, Li Z, Li J, Wang B, Zhou D, Dong J.
    Medicine (Baltimore); 2015 Sep 29; 94(36):e1462. PubMed ID: 26356700
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
    Meads C, Auguste P, Davenport C, Małysiak S, Sundar S, Kowalska M, Zapalska A, Guest P, Thangaratinam S, Martin-Hirsch P, Borowiack E, Barton P, Roberts T, Khan K.
    Health Technol Assess; 2013 Mar 29; 17(12):1-323. PubMed ID: 23537558
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET/CT and histology for diagnosing recurrent/remnant tumors in head and neck cancer patients treated with radiotherapy.
    Han EJ, O JH, Yoo IR, Kim YS, Kim MS, Kang JH, Choi WH.
    Hell J Nucl Med; 2017 Mar 29; 20(2):134-140. PubMed ID: 28697190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.